SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-T - Tender offer statement by Third Party:
SEC Accession No. 0001193125-16-729343
Filing Date
2016-10-03
Accepted
2016-10-03 16:25:30
Documents
11
Group Members
ALLERGAN HOLDCO US, INC.SAPPHIRE ACQUISITION CORP.

Document Format Files

Seq Description Document Type Size
1 SC TO-T d53050dsctot.htm SC TO-T 53629
2 EX-99.(A)(1)(A) d53050dex99a1a.htm EX-99.(A)(1)(A) 527048
3 EX-99.(A)(1)(B) d53050dex99a1b.htm EX-99.(A)(1)(B) 171928
4 EX-99.(A)(1)(C) d53050dex99a1c.htm EX-99.(A)(1)(C) 26049
5 EX-99.(A)(1)(D) d53050dex99a1d.htm EX-99.(A)(1)(D) 12920
6 EX-99.(A)(1)(E) d53050dex99a1e.htm EX-99.(A)(1)(E) 24175
7 EX-99.(A)(1)(I) d53050dex99a1i.htm EX-99.(A)(1)(I) 32975
8 EX-99.(D)(2) d53050dex99d2.htm EX-99.(D)(2) 23949
9 GRAPHIC g53050g40i44.jpg GRAPHIC 20017
10 GRAPHIC g53050g48t94.jpg GRAPHIC 29996
11 GRAPHIC g53050g58h06.jpg GRAPHIC 8868
  Complete submission text file 0001193125-16-729343.txt   956283
Mailing Address 701 GATEWAY BLVD SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-741-6625
Tobira Therapeutics, Inc. (Subject) CIK: 0001311596 (see all company filings)

IRS No.: 030422069 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T | Act: 34 | File No.: 005-87592 | Film No.: 161915998
SIC: 2834 Pharmaceutical Preparations

Mailing Address CLONSHAUGH BUSINESS AND TECHNOLOGY PARK COOLOCK, DUBLIN L2 D17 E400
Business Address CLONSHAUGH BUSINESS AND TECHNOLOGY PARK COOLOCK, DUBLIN L2 D17 E400 (216) 523-5000
Allergan plc (Filed by) CIK: 0001578845 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: SC TO-T
SIC: 2834 Pharmaceutical Preparations